Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	hydrolase activity, acting on ester bonds	PLB1 IMPA2 DCPS ACP2 PIWIL2 PNLDC1 MINPP1 PLA2G4E TOE1 ABHD4 MTMR4 PPP2R5D PTPRK PTPRM PLA2G1B PLCB4 GNAS CPSF3	1.28e-04	807	165	18	GO:0016788
GeneOntologyMolecularFunction	RNA transmembrane transporter activity	SIDT1 SIDT2	2.03e-04	3	165	2	GO:0051033
GeneOntologyMolecularFunction	nucleic acid transmembrane transporter activity	SIDT1 SIDT2	2.03e-04	3	165	2	GO:0051032
Domain	SID-1_RNA_chan	SIDT1 SIDT2	7.20e-05	2	159	2	PF13965
Domain	SID1_TM_fam	SIDT1 SIDT2	7.20e-05	2	159	2	IPR025958
Domain	ConA-like_dom	NBEAL1 COL27A1 SVEP1 RYR1 FAT2 MALRD1 PTPRK PTPRM USH2A	1.11e-04	219	159	9	IPR013320
Pathway	KEGG_LONG_TERM_DEPRESSION	PLA2G4E RYR1 GUCY1A1 PLA2G1B PLCB4 GNAS MAP2K1	1.31e-06	70	112	7	M8232
Pathway	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	PLA2G4E GUCY1A1 PLA2G1B PRKCE PLCB4 GNAS MAP2K1	3.58e-05	115	112	7	M9387
Pathway	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	PLA2G4E GAB2 BTK PLA2G1B PRKCE MAP2K1	3.81e-05	79	112	6	M11816
Pubmed	The nucleoporin MEL-28 promotes RanGTP-dependent γ-tubulin recruitment and microtubule nucleation in mitotic spindle formation.	NUP107 TUBGCP6 NUP160	5.98e-06	8	167	3	24509916
Pubmed	Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes.	PPP2R5C PPP2R5D MAP2K1	8.94e-06	9	167	3	16239230
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 GAPVD1 MAP1B CEP85L COBLL1 PSD3 LYST GAB2 SLC38A2 MTMR4 PRKCE TANC1 GNAS MAP2K1 PML	1.91e-05	861	167	15	36931259
Pubmed	Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific death.	UBE3A PML	2.29e-05	2	167	2	25231954
Pubmed	Intranuclear dynamics of the Nup107-160 complex.	NUP107 NUP160	2.29e-05	2	167	2	25904327
Pubmed	Lymphoblastic lymphoma in a colony of N:NIH(S)-bg-nu-xid mice.	LYST BTK	2.29e-05	2	167	2	1434498
Pubmed	PTPRM methylation induced by FN1 promotes the development of glioblastoma by activating STAT3 signalling.	FN1 PTPRM	2.29e-05	2	167	2	34225581
Pubmed	The Nup107-160 nucleoporin complex promotes mitotic events via control of the localization state of the chromosome passenger complex.	NUP107 NUP160	2.29e-05	2	167	2	19864462
Pubmed	A novel family of mammalian transmembrane proteins involved in cholesterol transport.	SIDT1 SIDT2	2.29e-05	2	167	2	28785058
Pubmed	Overexpression of GPC6 and TMEM132D in Early Stage Ovarian Cancer Correlates with CD8+ T-Lymphocyte Infiltration and Increased Patient Survival.	GPC6 TMEM132D	2.29e-05	2	167	2	26448945
Pubmed	Phosphorylation of serine 399 in LKB1 protein short form by protein kinase Cζ is required for its nucleocytoplasmic transport and consequent AMP-activated protein kinase (AMPK) activation.	STK11 PRKCE	2.29e-05	2	167	2	23612973
Pubmed	Determinants of receptor tyrosine phosphatase homophilic adhesion: Structural comparison of PTPRK and PTPRM extracellular domains.	PTPRK PTPRM	2.29e-05	2	167	2	36436563
Pubmed	Molecular and immunological approaches to mammalian fertilization.	ZPBP ZP2	2.29e-05	2	167	2	10924747
Pubmed	The Nup107-160 nucleoporin complex is required for correct bipolar spindle assembly.	NUP107 NUP160	2.29e-05	2	167	2	16807356
Pubmed	Systemic RNA Interference Deficiency-1 (SID-1) Extracellular Domain Selectively Binds Long Double-stranded RNA and Is Required for RNA Transport by SID-1.	SIDT1 SIDT2	2.29e-05	2	167	2	26067272
Pubmed	A Single Mechanism of Biogenesis, Initiated and Directed by PIWI Proteins, Explains piRNA Production in Most Animals.	PIWIL2 PNLDC1	2.29e-05	2	167	2	30193099
Pubmed	Homophilic interactions mediated by receptor tyrosine phosphatases mu and kappa. A critical role for the novel extracellular MAM domain.	PTPRK PTPRM	2.29e-05	2	167	2	7782276
Pubmed	Regulation of dendritic spines, spatial memory, and embryonic development by the TANC family of PSD-95-interacting proteins.	TANC2 TANC1	2.29e-05	2	167	2	21068316
Pubmed	Genetics of resistance to infection with Candida albicans in mice.	LYST BTK	6.85e-05	3	167	2	3058198
Pubmed	Tanc1/2 TPR domain interacts with Myo18a C-terminus and undergoes liquid-liquid phase separation.	TANC2 TANC1	6.85e-05	3	167	2	38092135
Pubmed	Mutations in the NUP93, NUP107 and NUP160 genes cause steroid-resistant nephrotic syndrome in Chinese children.	NUP107 NUP160	6.85e-05	3	167	2	38650033
Pubmed	A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells.	F2RL1 PRKCE	6.85e-05	3	167	2	16079188
Pubmed	Role of x-linked immunodeficiency (xid) and NK activity in rejection of human tumor xenotransplants in nude mice.	LYST BTK	6.85e-05	3	167	2	8329195
Pubmed	The CRTC1-NEDD9 signaling axis mediates lung cancer progression caused by LKB1 loss.	NEDD9 STK11	6.85e-05	3	167	2	23074285
Pubmed	New immunodeficient mouse strains bred by introducing beige and xid mutations into the KSN nude strain.	LYST BTK	6.85e-05	3	167	2	8872993
Pubmed	Frontrunners of T cell activation: Initial, localized Ca2+ signals mediated by NAADP and the type 1 ryanodine receptor.	TRPM2 RYR1	6.85e-05	3	167	2	26462735
Pubmed	Aberrant NRP-1 expression serves as predicator of metastatic endometrial and lung cancers.	NEDD9 STK11	6.85e-05	3	167	2	26701889
Pubmed	Enhanced human tumor cell transplantability in a new congenic immunodeficient mouse; KSN-BNX.	LYST BTK	6.85e-05	3	167	2	9821307
Pubmed	The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.	DIRAS3 MAP2K1	6.85e-05	3	167	2	23157514
Pubmed	E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.	UBE3A PML	6.85e-05	3	167	2	22689861
Pubmed	E6AP promotes the degradation of the PML tumor suppressor.	UBE3A PML	6.85e-05	3	167	2	19325566
Pubmed	NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition.	NEDD9 STK11	6.85e-05	3	167	2	24174333
Pubmed	Proteinase-activated receptor 2 promotes cancer cell migration through RNA methylation-mediated repression of miR-125b.	F2RL1 GAB2	6.85e-05	3	167	2	26354435
Pubmed	Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth.	PPP2R5C PPP2R5D	6.85e-05	3	167	2	25972378
Pubmed	The Nup107-160 complex and gamma-TuRC regulate microtubule polymerization at kinetochores.	NUP107 NUP160	6.85e-05	3	167	2	20081840
Pubmed	MUC5B mucin production is upregulated by fibronectin and laminin in human lung epithelial cells via the integrin and ERK dependent pathway.	FN1 MUC5B	6.85e-05	3	167	2	26057585
Pubmed	Description of clinical features and genetic analysis of one ultra-rare (SPG64) and two common forms (SPG5A and SPG15) of hereditary spastic paraplegia families.	ENTPD1 ZFYVE26	6.85e-05	3	167	2	33771085
Pubmed	Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.	ACE2 PREP	6.85e-05	3	167	2	23392115
Pubmed	The NIH-3 immunodeficient mouse is a model for Lyme borreliosis myositis and carditis.	LYST BTK	6.85e-05	3	167	2	1632468
Pubmed	The SUMO-specific isopeptidase SENP2 associates dynamically with nuclear pore complexes through interactions with karyopherins and the Nup107-160 nucleoporin subcomplex.	NUP107 NUP160	6.85e-05	3	167	2	22031293
Pubmed	Expression of the B56delta subunit of protein phosphatase 2A and Mea1 in mouse spermatogenesis. Identification of a new B56gamma subunit (B56gamma4) specifically expressed in testis.	PPP2R5C PPP2R5D	6.85e-05	3	167	2	15051958
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	GAPVD1 FN1 NUP107 MAP1B ACLY HEATR1 TEX10 PREP SUPT6H ANKRD28 CPSF3 NUP160	8.11e-05	653	167	12	22586326
Pubmed	Genetic mapping of 20 novel expressed sequence tags from midgestation mouse embryos suggests chromosomal clustering.	CHML LYST MED25	9.96e-05	19	167	3	9070936
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	IMPA2 LRRN1 MAP1B TRPM2 POMT1 COG3 GUCY1A1 SUPT6H ACKR3 XPNPEP3 ENTPD1 EXOC6B PRKCE PLCB4 DHRSX TANC1 GNAS GPT2 VPS13B	1.05e-04	1489	167	19	28611215
Pubmed	Cardiac pericytes mediate the remodeling response to myocardial infarction.	FN1 TBX18	1.37e-04	4	167	2	37183820
Pubmed	Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1.	PPP2R5C PPP2R5D	1.37e-04	4	167	2	18056802
Pubmed	PAK kinases are directly coupled to the PIX family of nucleotide exchange factors.	ARHGEF7 ARHGEF6	1.37e-04	4	167	2	9659915
Pubmed	A tyrosine-phosphorylated protein that binds to an important regulatory region on the cool family of p21-activated kinase-binding proteins.	ARHGEF7 ARHGEF6	1.37e-04	4	167	2	10428811
Pubmed	The Cool-2/alpha-Pix protein mediates a Cdc42-Rac signaling cascade.	ARHGEF7 ARHGEF6	1.37e-04	4	167	2	15649357
Pubmed	Differential expression of MAM-subfamily protein tyrosine phosphatases during mouse development.	PTPRK PTPRM	1.37e-04	4	167	2	9510027
Pubmed	Hair-Cell Mechanotransduction Persists in TRP Channel Knockout Mice.	TRPM2 PKD1L3	1.37e-04	4	167	2	27196058
Pubmed	Interaction of alphaPIX (ARHGEF6) with beta-parvin (PARVB) suggests an involvement of alphaPIX in integrin-mediated signaling.	ARHGEF7 ARHGEF6	1.37e-04	4	167	2	12499396
Pubmed	Cross-Reactive Antigen Expressed by B6 Splenocytes Drives Receptor Editing and Marginal Zone Differentiation of IgG2a-Reactive AM14 Vκ8 B Cells.	BTK UNC93B1	1.37e-04	4	167	2	31534009
Pubmed	The Cbl proteins are binding partners for the Cool/Pix family of p21-activated kinase-binding proteins.	ARHGEF7 ARHGEF6	1.37e-04	4	167	2	12935897
Pubmed	An evolutionarily conserved NPC subcomplex, which redistributes in part to kinetochores in mammalian cells.	NUP107 NUP160	1.37e-04	4	167	2	11564755
Pubmed	Strain-dependent leakiness of mice with severe combined immune deficiency.	LYST BTK	1.37e-04	4	167	2	8473734
Pubmed	Novel regulatory mechanisms for the Dbl family guanine nucleotide exchange factor Cool-2/alpha-Pix.	ARHGEF7 ARHGEF6	1.37e-04	4	167	2	15306850
Pubmed	Acidosis Mediates the Switching of Gs-PKA and Gi-PKCε Dependence in Prolonged Hyperalgesia Induced by Inflammation.	PRKCE GNAS	1.37e-04	4	167	2	25933021
Pubmed	Expanding functions of GIT Arf GTPase-activating proteins, PIX Rho guanine nucleotide exchange factors and GIT-PIX complexes.	ARHGEF7 ARHGEF6	1.37e-04	4	167	2	27182061
Pubmed	Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome.	NUP107 NUP160	1.37e-04	4	167	2	30179222
Pubmed	The LIM protein leupaxin is enriched in smooth muscle and functions as an serum response factor cofactor to induce smooth muscle cell gene transcription.	MINPP1 LPXN	1.37e-04	4	167	2	18497331
Pubmed	Novel vertebrate nucleoporins Nup133 and Nup160 play a role in mRNA export.	NUP107 NUP160	1.37e-04	4	167	2	11684705
Pubmed	Involvement of Parkin in the ubiquitin proteasome system-mediated degradation of N-type voltage-gated Ca2+ channels.	MAP1B UBE3A	1.37e-04	4	167	2	28957379
Pubmed	B cell receptor signaling in germinal centers prolongs survival and primes B cells for selection.	BTK LY75	1.37e-04	4	167	2	36882061
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PSD3 CSMD3 KLHL32 PCDH19 OTUD4 DISP2 SLC9A6 VPS13B SEZ6L	1.66e-04	407	167	9	12693553
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	NUP107 MAP1B MYH7B COL27A1 RRN3 USP39 NUP160	2.18e-04	250	167	7	33536335
Pubmed	Assignment of human protein phosphatase 2A regulatory subunit genes b56alpha, b56beta, b56gamma, b56delta, and b56epsilon (PPP2R5A-PPP2R5E), highly expressed in muscle and brain, to chromosome regions 1q41, 11q12, 3p21, 6p21.1, and 7p11.2 --> p12.	PPP2R5C PPP2R5D	2.27e-04	5	167	2	8812429
Pubmed	Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models.	LYST BTK	2.27e-04	5	167	2	23885715
Pubmed	Genomic organisation, chromosomal localisation tissue distribution and developmental regulation of the PR61/B' regulatory subunits of protein phosphatase 2A in mice.	PPP2R5C PPP2R5D	2.27e-04	5	167	2	15095873
Pubmed	Paxillin-dependent paxillin kinase linker and p21-activated kinase localization to focal adhesions involves a multistep activation pathway.	ARHGEF7 ARHGEF6	2.27e-04	5	167	2	12006652
Pubmed	IL-23 Inhibits Melanoma Development by Augmenting DNA Repair and Modulating T Cell Subpopulations.	LYST BTK	2.27e-04	5	167	2	28003381
Pubmed	Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells.	RYR1 PRKCE	2.27e-04	5	167	2	19011160
Pubmed	GIT1 utilizes a focal adhesion targeting-homology domain to bind paxillin.	ARHGEF7 LPXN	2.27e-04	5	167	2	17467235
Pubmed	The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C.	BTK PRKCE	2.27e-04	5	167	2	7522330
Pubmed	Expression and function of the SDF-1 chemokine receptors CXCR4 and CXCR7 during mouse limb muscle development and regeneration.	FN1 ACKR3	2.27e-04	5	167	2	22766125
Pubmed	A PP1-PP2A phosphatase relay controls mitotic progression.	PPP2R5C PPP2R5D	2.27e-04	5	167	2	25487150
Pubmed	Odorant receptors can mediate axonal identity and gene choice via cAMP-independent mechanisms.	OR8A1 GNAS	2.27e-04	5	167	2	27466441
Pubmed	Activation of the Hh pathway in periosteum-derived mesenchymal stem cells induces bone formation in vivo: implication for postnatal bone repair.	LYST BTK	2.27e-04	5	167	2	20971735
Pubmed	The p21-activated kinase PAK is negatively regulated by POPX1 and POPX2, a pair of serine/threonine phosphatases of the PP2C family.	ARHGEF7 ARHGEF6	2.27e-04	5	167	2	11864573
Pubmed	Antigens recognized by autologous antibody in patients with renal-cell carcinoma.	NEDD9 STK11 PPP2R5C UBE3A	2.45e-04	63	167	4	10508479
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	GAPVD1 FN1 HEATR1 KLHL32 TUB SMTN SLC38A2 STK11 SEPSECS PPP2R5C NFE2L1 OTUD4 VPS13B ARHGEF6 PML	2.47e-04	1084	167	15	11544199
Pubmed	Bioinformatics and cellular signaling.	FN1 ACLY RYR1 GAB2 ARHGEF7 BTK	2.59e-04	182	167	6	15102471
Pubmed	Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan.	ACOX1 ARFGEF1 TUBGCP6 UBE3A PREP EXOC6B	2.67e-04	183	167	6	31932471
Pubmed	Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.	MPP2 ARHGEF7 BTK	3.26e-04	28	167	3	18067320
Pubmed	Interaction of Bruton's tyrosine kinase and protein kinase Ctheta in platelets. Cross-talk between tyrosine and serine/threonine kinases.	BTK PRKCE	3.39e-04	6	167	2	11788586
Pubmed	Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney.	ACE2 PREP	3.39e-04	6	167	2	27649628
Pubmed	Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and Toll-like receptors.	BTK UNC93B1	3.39e-04	6	167	2	17658280
Pubmed	Isolation of murine SPT5 homologue: completion of the isolation and characterization of human and murine homologues of yeast chromatin structural protein complex SPT4, SPT5, and SPT6.	RYR1 SUPT6H	3.39e-04	6	167	2	9480761
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	MAP1B CEP85L TEX10 STK11 LRR1 RRN3 SUPT6H PRIM2 OTUD4 ANKRD28 USP39 GPT2 SGF29 NUP160	3.73e-04	1005	167	14	19615732
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	TDRD15 GAPVD1 FN1 NUP107 ARFGEF1 GAB2 SEMA4C SLC38A2 FRRS1 ANKRD28 HNRNPLL NUP160	3.99e-04	777	167	12	35844135
Pubmed	Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.	PSD3 TUB RYR1	4.01e-04	30	167	3	20080650
Pubmed	Large-scale concatenation cDNA sequencing.	CEP85L ACP2 COG3 SSTR2 SUPT6H EDEM2 MED25 UNC93B1 CTNND2 RRN3P1	4.48e-04	568	167	10	9110174
Pubmed	Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.	NEDD9 ARHGEF7 LPXN OTUD4 ARHGEF6	4.71e-04	133	167	5	15144186
Pubmed	The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm.	PPP2R5C PPP2R5D	4.74e-04	7	167	2	8703017
Pubmed	Zebrin II Is Ectopically Expressed in Microglia in the Cerebellum of Neurogenin 2 Null Mice.	ACP2 PLCB4	4.74e-04	7	167	2	29909450
Pubmed	Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.	PCDH19 SLC9A6	4.74e-04	7	167	2	25818041
Pubmed	The X-linked lymphoproliferative disease gene product SAP associates with PAK-interacting exchange factor and participates in T cell activation.	ARHGEF7 ARHGEF6	4.74e-04	7	167	2	16983070
Pubmed	The GIT family of ADP-ribosylation factor GTPase-activating proteins. Functional diversity of GIT2 through alternative splicing.	ARHGEF7 ARHGEF6	4.74e-04	7	167	2	10896954
Pubmed	Laminin-10/11 and fibronectin differentially prevent apoptosis induced by serum removal via phosphatidylinositol 3-kinase/Akt- and MEK1/ERK-dependent pathways.	FN1 MAP2K1	4.74e-04	7	167	2	11891225
Pubmed	N-α-acetyltransferase 10 protein suppresses cancer cell metastasis by binding PIX proteins and inhibiting Cdc42/Rac1 activity.	ARHGEF7 ARHGEF6	4.74e-04	7	167	2	21295525
GeneFamily	Phospholipases	PLB1 PLA2G4E PLA2G1B PLCB4	1.44e-04	42	115	4	467
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	PAMR1 CSMD3 SVEP1 SEZ6L	4.73e-04	57	115	4	1179
GeneFamily	Phosphoinositide phosphatases	IMPA2 MINPP1 MTMR4	1.09e-03	32	115	3	1079
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEAL1 LYST	1.40e-03	9	115	2	1230
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	FN1 NBEAL1 COBLL1 PSD3 LYST ABHD4 NEDD9 SEPSECS PTPRK ACKR3 EXOC6B CTNND2 TBC1D23 ZNF654	4.03e-06	504	165	14	M2157
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 NR6A1 GAB2 PTPRK PTPRM EXOC6B PRKCE TANC1 VPS13B	6.34e-08	198	167	9	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MPP2 COBLL1 SSTR2 SMTN GUCY1A1 PCDH19 LTBP2 ARHGEF6	3.34e-07	175	167	8	2a53d4f140d5ab096efe8118d8aa351db7838b49
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MPP2 COBLL1 SSTR2 SMTN GUCY1A1 PCDH19 LTBP2 ARHGEF6	3.34e-07	175	167	8	fb91a45763e4c48d993094a13088ffc19f1e2574
ToppCell	facs-Lung-nan-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 COBLL1 SSTR2 SMTN GUCY1A1 PCDH19 LTBP2 ARHGEF6	3.96e-07	179	167	8	7078022e60faa86444f2a2c6eb9f767cc66b5cfa
ToppCell	facs-Lung-nan-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 COBLL1 SSTR2 SMTN GUCY1A1 PCDH19 LTBP2 ARHGEF6	3.96e-07	179	167	8	d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	FN1 NBEAL1 COBLL1 GPC6 SMTN NEDD9 ENTPD1 PLCB4	5.99e-07	189	167	8	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CEP85L HYAL1 PTPRM GUCY1A1 PRKCE PLCB4 TANC1 CTNND2	6.74e-07	192	167	8	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CEP85L HYAL1 COBLL1 PTPRM GUCY1A1 PRKCE PLCB4 TANC1	7.01e-07	193	167	8	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MPP2 COBLL1 GPC6 SMTN GUCY1A1 LTBP2 GNAS ARHGEF6	7.88e-07	196	167	8	6708026bafd19c35c5c4e81911344d36a0f508cd
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	TANC2 FN1 PSD3 ENTPD1 PLCB4 TANC1 LTBP2 VPS13B	8.18e-07	197	167	8	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 COBLL1 SSTR2 ACE2 GUCY1A1 PCDH19 LTBP2	4.15e-06	173	167	7	3059325901b1e5e12a1a91183f14267288b2f600
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 COBLL1 SSTR2 ACE2 GUCY1A1 PCDH19 LTBP2	4.15e-06	173	167	7	36c8338463ee4cc432f568728d55989360f9a68d
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 SMTN SEMA4C GUCY1A1 PCDH19 TANC1 LTBP2	5.39e-06	180	167	7	f6a05b3751b01e74b2de8440801b0eb2e723c199
ToppCell	droplet-Lung-nan-18m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 SMTN SEMA4C GUCY1A1 PCDH19 TANC1 LTBP2	5.39e-06	180	167	7	dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1
ToppCell	E12.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SEMA4F COL27A1 F2RL1 NEDD9 SAMD10 PLA2G1B CTNND2	5.80e-06	182	167	7	204530444e35d4977a7239ac176f477e9e5c29ab
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	FN1 NBEAL1 COBLL1 GUCY1A1 ARHGEF7 ENTPD1 PLCB4	6.01e-06	183	167	7	818fd886e0188091310825f9145fa53328f2c979
ToppCell	LV-07._Pericyte\|World / Chamber and Cluster_Paper	IMPA2 MAP1B NBEAL1 COL27A1 GUCY1A1 ARHGEF7 PLCB4	6.01e-06	183	167	7	273db6a3b00a93ca852498471187b642b5368185
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PAMR1 ZPBP COL27A1 GPC6 SMTN FAH PTPRM	6.23e-06	184	167	7	7d41784eac0935e77d6bc701f20c693adf998730
ToppCell	LV-07._Pericyte\|LV / Chamber and Cluster_Paper	IMPA2 MAP1B NBEAL1 COL27A1 GUCY1A1 ARHGEF7 PLCB4	6.45e-06	185	167	7	acb38eba871ec72f2a8136a33b87d33b8c85465d
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	MYH7B COL27A1 NR6A1 PRIM2 EXOC6B PLCB4 CTNND2	6.68e-06	186	167	7	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	MYH7B COL27A1 NR6A1 PRIM2 EXOC6B PLCB4 CTNND2	6.68e-06	186	167	7	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	FN1 PAMR1 GPC6 SVEP1 GAB2 ACKR3 LTBP2	6.92e-06	187	167	7	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	Cerebellum-Neuronal\|Cerebellum / BrainAtlas - Mouse McCarroll V32	MAP1B TRPM2 PANX2 TUB TUBGCP6 SAMD10 DISP2	6.92e-06	187	167	7	61b9d6eb131a674598aa8409d7fa909c8765442d
ToppCell	RV-07._Pericyte\|World / Chamber and Cluster_Paper	MAP1B COL27A1 SSTR2 ACE2 GUCY1A1 ARHGEF7 PLCB4	6.92e-06	187	167	7	dc274d6bbda619a2c914d84e2b4069cfef1739d1
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	COL27A1 COBLL1 NR6A1 LYST PTPRK CTNND2 GPT2	6.92e-06	187	167	7	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	FN1 NBEAL1 COBLL1 SMTN NEDD9 ENTPD1 PLCB4	7.17e-06	188	167	7	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	facs-Pancreas\|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRN1 MAP1B PAMR1 KLHL32 DISP2 CTNND2 SEZ6L	7.95e-06	191	167	7	d48e5f67d384226add7d7fb2a124954136e09a82
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRN1 MAP1B ACLY KLHL32 SEPSECS DISP2 SEZ6L	7.95e-06	191	167	7	f76f3f5c7902a3659d8cbe470f96ce57c8a6744d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 MAP1B CDK15 SLC38A2 GUCY1A1 ARHGEF7 PLCB4	7.95e-06	191	167	7	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 MAP1B CDK15 SLC38A2 GUCY1A1 ARHGEF7 PLCB4	7.95e-06	191	167	7	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRN1 ACLY KLHL32 SEPSECS DISP2 USH2A SEZ6L	8.22e-06	192	167	7	5b7093d5af5ae7b0e6d3a464cc56272440ecedad
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 MAP1B CDK15 COBLL1 TMEM38B ACE2 GUCY1A1	8.50e-06	193	167	7	1043b28503bfaa0d5a82ec358bc86cbde73ea8f2
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TANC2 MANBA GAB2 PTPRM PRKCE MAP2K1 VPS13B	8.50e-06	193	167	7	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CEP85L IFNAR2 NEDD9 PTPRM ENTPD1 PLCB4 CTNND2	8.50e-06	193	167	7	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CEP85L IFNAR2 NEDD9 PTPRM ENTPD1 PLCB4 CTNND2	8.50e-06	193	167	7	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	COL27A1 COBLL1 NR6A1 GPC6 FRRS1 PTPRK GPT2	8.50e-06	193	167	7	503a979328c68b096680b71359a26f02fafdff35
ToppCell	LA\|World / Chamber and Cluster_Paper	FN1 MAP1B GPC6 SVEP1 GAB2 ACKR3 LTBP2	8.50e-06	193	167	7	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	moderate-Myeloid-Monocyte-derived_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FN1 SSTR2 SIDT2 RSAD2 UNC93B1 HNRNPLL PML	8.50e-06	193	167	7	22455801194bd8c73c5c397f5eac4f723429c383
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MPP2 COBLL1 SSTR2 GUCY1A1 LTBP2 GNAS ARHGEF6	9.09e-06	195	167	7	4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	FN1 PAMR1 GPC6 SVEP1 GAB2 ACKR3 LTBP2	9.09e-06	195	167	7	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MPP2 COBLL1 SSTR2 GUCY1A1 LTBP2 GNAS ARHGEF6	9.09e-06	195	167	7	7a32a8535c29b819dacba901d0658280a2631c94
ToppCell	Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLAC1 MAP1B CYP27C1 SSTR2 TUB PCDH19 NBPF10	9.72e-06	197	167	7	06e17c9ad53463eee1007280b3f3e8b0cf446cdc
ToppCell	metastatic_Brain-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	MAP1B COBLL1 SSTR2 SMTN PTPRK GUCY1A1 ENTPD1	1.00e-05	198	167	7	86a4c8e859ce11a95875f8844963baeb1ba898ec
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1B PAMR1 COL27A1 GPC6 SMTN GUCY1A1 LTBP2	1.00e-05	198	167	7	b258f672529fb2c03e62e2696d335043c4963280
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1B PAMR1 COL27A1 GPC6 SMTN GUCY1A1 LTBP2	1.00e-05	198	167	7	a699b365d3b6149f13f02b2e2ae9b6fdce761848
ToppCell	Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PAMR1 LRR1 ACKR3 PCDH19 PLCB4 GPT2 TMEM255A	1.07e-05	200	167	7	5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	MAP1B GPR31 ZPBP COL27A1 SEPSECS LTBP2	1.37e-05	138	167	6	8d70e64843f7c3be8ee4203cc126fdf1001f0df5
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	CSMD3 RYR1 MALRD1 TMEM132D CTNND2 USH2A	1.43e-05	139	167	6	64c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	CSMD3 SLC26A8 TMEM132D CTNND2 USH2A SEZ6L	1.89e-05	146	167	6	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	PND01-03-samps-Mesenchymal-Pericyte\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	MPP2 SSTR2 LRR1 GUCY1A1 LTBP2 ARHGEF6	2.37e-05	152	167	6	fc9472bc19f997103da535b035105f01429cb08e
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	MPP2 MAP1B PNLDC1 SMTN PLCB4 LTBP2	3.27e-05	161	167	6	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP27C1 NR6A1 SSTR2 NEDD9 PTPRK NBPF10	3.27e-05	161	167	6	0d863d7d369391dd6148e1de6d6f8033dcb8fe0f
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	CDK15 CSMD3 RYR1 TMEM132D CTNND2 USH2A	3.51e-05	163	167	6	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	Adult-Mesenchymal-chondrocyte-D175\|Adult / Lineage, Cell type, age group and donor	MAP1B COL27A1 GPC6 TBX18 ACKR3 LTV1	4.15e-05	168	167	6	14071b961c9bdb54a8259b12a88237b802cbde36
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PAMR1 GPC6 SVEP1 TBX18 LTBP2 TMEM255A	4.15e-05	168	167	6	4b2d29a7843bf45922038c093ca7ec0600756adc
ToppCell	facs-Lung-Endomucin-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 SSTR2 SMTN TBX18 GUCY1A1 ARHGEF6	4.29e-05	169	167	6	2d23b4cee060f8adddc430c1c10d4e25205b4af6
ToppCell	facs-Lung-Endomucin-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 SSTR2 SMTN TBX18 GUCY1A1 ARHGEF6	4.29e-05	169	167	6	ecaf08e8e0b54d1c97a02bc1f65409fd43d68227
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FN1 CYP27C1 GPC6 SVEP1 PCDH19 TANC1	4.29e-05	169	167	6	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	facs-Lung-Endomucin-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 SSTR2 SMTN TBX18 GUCY1A1 ARHGEF6	4.29e-05	169	167	6	ad6af6609acf158cb79e45ee7ca9af332be3c40c
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	MAP1B SSTR2 GPC6 TBX18 GUCY1A1 PLCB4	4.73e-05	172	167	6	c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MPP2 COBLL1 ZNF112 SSTR2 GUCY1A1 ARHGEF6	4.73e-05	172	167	6	03a0aff6b7971093a4347b5ed12546d78374c56f
ToppCell	droplet-Mammary_Gland-nan-3m-Endothelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA4C RSAD2 ARHGEF7 TANC1 ZNF606 TMEM255A	4.89e-05	173	167	6	fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SSTR2 SMTN GUCY1A1 PCDH19 GNAS ARHGEF6	5.21e-05	175	167	6	3e56695a9db97cb1d3503425c48eb79bbf99213e
ToppCell	droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLB1 SVEP1 HSF5 SEPSECS MTMR4 LY75	5.55e-05	177	167	6	4672cc75225a4a23b298afa8ce439628262519db
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 COBLL1 SMTN GUCY1A1 PCDH19 LTBP2	5.91e-05	179	167	6	bfc226bcf0b93525992344f968268a261d86fcbf
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 COBLL1 SMTN GUCY1A1 PCDH19 LTBP2	5.91e-05	179	167	6	36ad18f52e175ab636ceaa3be81212fa362c96c1
ToppCell	E18.5-samps-Mesenchymal-Pericyte\|E18.5-samps / Age Group, Lineage, Cell class and subclass	COBLL1 SSTR2 SMTN GUCY1A1 GNAS ARHGEF6	6.09e-05	180	167	6	0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70
ToppCell	facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B CDK15 COBLL1 GPC6 TMEM38B GUCY1A1	6.28e-05	181	167	6	429df38438d5a7ff490c9ede34b69e2970c7ded2
ToppCell	facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B CDK15 COBLL1 GPC6 TMEM38B GUCY1A1	6.28e-05	181	167	6	395cf5aa2d89b05328ab516b8c89401020b6d830
ToppCell	COVID-19-Heart-Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAP1B COL27A1 ACE2 GUCY1A1 ARHGEF7 PLCB4	6.28e-05	181	167	6	33cac65ed1ea5e7bd72250495df4f850b143d5aa
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	FN1 MAP1B NBEAL1 COL27A1 GUCY1A1 ARHGEF7	6.48e-05	182	167	6	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	LA-07._Pericyte\|World / Chamber and Cluster_Paper	MAP1B NBEAL1 COL27A1 GUCY1A1 ARHGEF7 PLCB4	6.68e-05	183	167	6	e3835db4795362b0442d5893baf2a78efcc20428
ToppCell	facs-Heart-RA-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 COBLL1 TMEM38B ACE2 GUCY1A1 PCDH19	6.68e-05	183	167	6	0f02136359787bd78146617990968baa47a65d86
ToppCell	facs-Heart-RA-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 COBLL1 TMEM38B ACE2 GUCY1A1 PCDH19	6.68e-05	183	167	6	2f0dcc65ad4d90ef946919b4462280fdd20c5ea0
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYH7B COBLL1 GPR160 GAB2 NFE2L1 PRIM2	6.88e-05	184	167	6	af6522586d012e91241f3e06c60f9d1881e95646
ToppCell	P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MPP2 SSTR2 GUCY1A1 PCDH19 LTBP2 ARHGEF6	6.88e-05	184	167	6	23c24ab5786af33d605bc445d06117b9da6c6331
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	MYH7B PSD3 PTPRM EXOC6B OR5K2 CTNND2	6.88e-05	184	167	6	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	COVID-19-Heart-Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	MAP1B NBEAL1 COL27A1 GUCY1A1 ARHGEF7 PLCB4	6.88e-05	184	167	6	21790cdfa3b4036ad413fd44b94e31563116f25f
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FN1 MAP1B PAMR1 SVEP1 TBX18 LTBP2	7.09e-05	185	167	6	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	LA-07._Pericyte\|LA / Chamber and Cluster_Paper	MAP1B NBEAL1 COL27A1 GUCY1A1 ARHGEF7 PLCB4	7.09e-05	185	167	6	ba5baa4d7f097108622674de5b7f4fd279843d24
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	MYH7B PSD3 PTPRM EXOC6B OR5K2 CTNND2	7.09e-05	185	167	6	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	RV-07._Pericyte\|RV / Chamber and Cluster_Paper	MAP1B COL27A1 SSTR2 GUCY1A1 ARHGEF7 PLCB4	7.30e-05	186	167	6	c533b264fbe12bc35467486fc7fbde24ba968fe1
ToppCell	E12.5-Epithelial\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SEMA4F F2RL1 NEDD9 SAMD10 PLA2G1B CTNND2	7.52e-05	187	167	6	29ea5e14dac3321df76f6aa4f053068b49c4a4bf
ToppCell	facs-Heart-LA-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IMPA2 COBLL1 ACE2 PTPRK GUCY1A1 PCDH19	7.52e-05	187	167	6	a12f383b02b07af32cc53a154685df8dba8fbd3f
ToppCell	facs-Heart-LA-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IMPA2 COBLL1 ACE2 PTPRK GUCY1A1 PCDH19	7.52e-05	187	167	6	c40c152fa14e6afc9188549534b64ccbaded56b3
ToppCell	droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 MYH7B COBLL1 TUB ACE2 GUCY1A1	7.52e-05	187	167	6	59313a47a6012b2413d7d3673bb05fb7e49fd88f
ToppCell	E12.5-Epithelial-epithelial_progenitor_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SEMA4F F2RL1 NEDD9 SAMD10 PLA2G1B CTNND2	7.52e-05	187	167	6	ab6f4d387218b4651fdadbf269806c1ddc96a1d2
ToppCell	E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MAP1B GPC6 GUCY1A1 LTBP2 GNAS ARHGEF6	7.52e-05	187	167	6	0dee138738b65531ff134a125b92234b5d0a653c
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HYAL1 PTPRM GUCY1A1 PRKCE PLCB4 CTNND2	7.75e-05	188	167	6	73f6ec915934154f435a376cb274b058ff7c5f35
ToppCell	Control\|World / Disease state, Lineage and Cell class	MANBA GAB2 IFNAR2 FAH SUPT6H MAP2K1	7.98e-05	189	167	6	fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COBLL1 SSTR2 GUCY1A1 PCDH19 LTBP2 ARHGEF6	8.21e-05	190	167	6	7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0
ToppCell	facs-Heart-RA-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 FN1 COBLL1 GPC6 ACE2 GUCY1A1	8.21e-05	190	167	6	bfbdf16d488359d7935a419c4c1823288f39c183
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HYAL1 COBLL1 PTPRM PRKCE PLCB4 TANC1	8.21e-05	190	167	6	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	facs-Heart-RA-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 FN1 COBLL1 GPC6 ACE2 GUCY1A1	8.21e-05	190	167	6	eb1f8bb4d903b08e50c2dc173b06c0c79d8e316e
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTPRM GUCY1A1 PRKCE PLCB4 TANC1 CTNND2	8.21e-05	190	167	6	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	MAP1B COL27A1 COBLL1 NEDD9 GUCY1A1 ARHGEF7	8.21e-05	190	167	6	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MPP2 SSTR2 GUCY1A1 LTBP2 GNAS ARHGEF6	8.21e-05	190	167	6	979b1476fd2692fde977ce56257315fcfc8a01d5
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTPRK PTPRM PRKCE PLCB4 TANC1 CTNND2	8.45e-05	191	167	6	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MPP2 PAMR1 SSTR2 SMTN GUCY1A1 LTBP2	8.45e-05	191	167	6	fd8331c7abdd999f55ba43d307945c6abfccbf84
ToppCell	droplet-Kidney-nan-18m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 GPC6 SVEP1 TBX18 GUCY1A1 LTBP2	8.70e-05	192	167	6	38d7a24ae205ef91ed2e0f402d8022f2a9cdb243
Drug	Trioxsalen [3902-71-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A	MAP1B PSD3 ARFGEF1 BLZF1 NEDD9 PPP2R5C ARHGEF7 SUPT6H CTNND2 NUP160	1.73e-06	197	164	10	6216_DN
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A	PLAC1 SEMA4F WIPI1 PSD3 LYST SVEP1 ARHGEF7 LTBP2 PML	1.05e-05	191	164	9	7417_UP
Drug	Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; HL60; HT_HG-U133A	FN1 SZT2 COBLL1 BLZF1 RYR1 SEMA4C STK11 PRKCE PML	1.30e-05	196	164	9	2951_UP
Drug	Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A	FN1 COBLL1 MUC5B SSTR2 SVEP1 CCKBR SIDT2 UBE3A MED25	1.35e-05	197	164	9	5633_UP
Drug	Trimethadione [127-48-0]; Up 200; 28uM; HL60; HT_HG-U133A	FN1 BLZF1 RYR1 PTPRM MED25 PLA2G1B PRKCE LTBP2 PML	1.41e-05	198	164	9	2486_UP
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; MCF7; HT_HG-U133A	MPP2 PIWIL2 CCKBR ADGB UBE3A MED25 EXOC6B PLA2G1B PML	1.41e-05	198	164	9	6106_UP
Drug	Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; MCF7; HT_HG-U133A	FN1 SZT2 TRPM2 SVEP1 ENTPD1 PLA2G1B PRKCE VPS13B PML	1.41e-05	198	164	9	3356_UP
Disease	1-stearoylglycerophosphocholine measurement	COBLL1 MALRD1	3.07e-05	2	164	2	EFO_0021092
Disease	protein C measurement, hematological measurement	MYH7B EDEM2	9.18e-05	3	164	2	EFO_0004503, EFO_0004633
Disease	protein C measurement	MYH7B CYP27C1 EDEM2	1.08e-04	17	164	3	EFO_0004633
Disease	coronary artery disease	TDRD15 WIPI1 FN1 MAP1B NBEAL1 PSD3 PKD1L3 TUB SVEP1 NEDD9 MALRD1 GUCY1A1 TMEM132D PRIM2 EDEM2 PRKCE NUP160 SEZ6L	1.23e-04	1194	164	18	EFO_0001645
Disease	pontocerebellar hypoplasia (implicated_via_orthology)	TOE1 TBC1D23	3.04e-04	5	164	2	DOID:0060264 (implicated_via_orthology)
Disease	response to bronchodilator, FEV/FEC ratio	MPP2 CFAP300 PAMR1 ZPBP HEATR1 MINPP1 GPC6 F2RL1 KLHL32 LYST FAT2 ACKR3 GNAS	3.71e-04	766	164	13	EFO_0004713, GO_0097366
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	GAPVD1 NUP107 NUP160	6.13e-04	30	164	3	C1868672
Disease	cholesteryl ester 16:2 measurement	SIDT2 LTBP2	6.33e-04	7	164	2	EFO_0021435
Disease	pulse pressure measurement	TDRD15 FN1 MAP1B NBEAL1 ACOX1 COL27A1 COBLL1 PKD1L3 SVEP1 TBX18 MALRD1 GUCY1A1 SUPT6H LPXN PRKCE LTBP2 CTNND2 NUP160	7.70e-04	1392	164	18	EFO_0005763
Disease	severe acute respiratory syndrome, COVID-19	TRPM2 PSD3 LYST SEPSECS MALRD1 ARHGEF7 DHRSX LTBP2 OR5K1	9.30e-04	447	164	9	EFO_0000694, MONDO_0100096
Disease	respiratory syncytial virus infectious disease (is_implicated_in)	ACE2 RSAD2	1.34e-03	10	164	2	DOID:1273 (is_implicated_in)
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	TDRD15 WIPI1 COBLL1 PSD3	1.37e-03	86	164	4	EFO_0008595, EFO_0020945
Disease	Nodular glomerulosclerosis	FN1 ACE2 PRKCE	1.54e-03	41	164	3	C0017667
Disease	peanut allergy measurement, parental genotype effect measurement	RYR1 ADGB	1.63e-03	11	164	2	EFO_0005939, EFO_0007017
Disease	Diabetic Nephropathy	FN1 ACE2 PRKCE	1.89e-03	44	164	3	C0011881
Disease	N-acetylputrescine measurement	PSD3 TUBGCP6	1.95e-03	12	164	2	EFO_0800127
Disease	Congenital muscular dystrophy	POMT1 RYR1	1.95e-03	12	164	2	cv:C0699743
Disease	Colorectal Carcinoma	FN1 MAP1B RBP3 ARFGEF1 CSMD3 SMTN STK11 ACKR3 PRKCE GNAS CTNND2	1.97e-03	702	164	11	C0009402
Disease	response to angiotensin-converting enzyme inhibitor, Cough	NEDD9 EXOC6B VPS13B	2.15e-03	46	164	3	EFO_0005325, HP_0012735
Disease	Congenital pontocerebellar hypoplasia	TOE1 SEPSECS	2.30e-03	13	164	2	C0266468
Disease	spontaneous preterm birth	MPP2 SVEP1 CCKBR GUCY1A1	2.47e-03	101	164	4	EFO_0006917
Disease	triglyceride measurement, alcohol consumption measurement	TDRD15 PLB1 COBLL1 PSD3	2.47e-03	101	164	4	EFO_0004530, EFO_0007878
Disease	melanoma	F2RL1 GAB2 STK11 PTPRK PLCB4 MAP2K1	2.71e-03	248	164	6	C0025202
Disease	polyunsaturated fatty acids to total fatty acids percentage	COBLL1 PSD3 RRN3	2.73e-03	50	164	3	EFO_0022303
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	COBLL1 PSD3 RRN3	2.89e-03	51	164	3	EFO_0022302
Disease	response to platinum based chemotherapy, magnesium measurement	PSD3 OTUD4	3.07e-03	15	164	2	EFO_0004647, EFO_0004845
Disease	Heschl's gyrus morphology measurement	COBLL1 NEDD9 DISP2	3.22e-03	53	164	3	EFO_0005852
Disease	free cholesterol to total lipids in small LDL percentage	COBLL1 PSD3 RRN3	3.22e-03	53	164	3	EFO_0022286
Disease	insomnia measurement	MPP2 TANC2 ZPBP TRPM2 CSMD3 CTNND2 MAP2K1 PML	3.46e-03	443	164	8	EFO_0007876
Disease	coronary artery disease, factor VII measurement	TDRD15 NBEAL1 PNLDC1 GUCY1A1	3.47e-03	111	164	4	EFO_0001645, EFO_0004619
Disease	4-acetamidobutanoate measurement	PSD3 PANX2	3.50e-03	16	164	2	EFO_0021003
Disease	triiodothyronine measurement	MPP2 PRKCE	3.50e-03	16	164	2	EFO_0008392
Disease	Pontoneocerebellar hypoplasia	SEPSECS TBC1D23	3.50e-03	16	164	2	cv:C1261175
Disease	Intellectual Disability	TANC2 MAP1B ACE2 PPP2R5D ENTPD1 GNAS TBC1D23 GPT2	3.66e-03	447	164	8	C3714756
Disease	triglycerides in LDL measurement	TDRD15 COBLL1 PSD3	3.77e-03	56	164	3	EFO_0022320
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	COBLL1 PSD3 RRN3	3.77e-03	56	164	3	EFO_0022316
Disease	cholesterol to total lipids in large LDL percentage	TDRD15 COBLL1 RRN3	3.77e-03	56	164	3	EFO_0022235
Disease	cholesteryl esters to total lipids in large VLDL percentage	TDRD15 COBLL1 RRN3	3.77e-03	56	164	3	EFO_0022250
Disease	creatinine measurement	PLAC1 GAPVD1 WIPI1 MANBA MYH7B FAM227B PKD1L3 TUB RYR1 GAB2 NFE2L1 EDEM2 GNAS	3.83e-03	995	164	13	EFO_0004518
Disease	free cholesterol to total lipids in medium VLDL percentage	TDRD15 COBLL1 RRN3	3.96e-03	57	164	3	EFO_0022284
Disease	apolipoprotein B measurement	TDRD15 FN1 COBLL1 PSD3 FAM227B PNLDC1 ZNF112 PKD1L3 SIDT2 XPNPEP3	4.09e-03	663	164	10	EFO_0004615
Disease	triglycerides in IDL measurement	TDRD15 COBLL1 PSD3	4.16e-03	58	164	3	EFO_0022149
Disease	Hypertensive disease	FN1 ACE2 STK11 GUCY1A1 GNAS	4.28e-03	190	164	5	C0020538
Disease	von Willebrand factor measurement, coronary artery disease	TDRD15 NBEAL1 PNLDC1 GUCY1A1	4.32e-03	118	164	4	EFO_0001645, EFO_0004629
Disease	triglycerides to total lipids in small LDL percentage	COBLL1 PSD3 RRN3	4.36e-03	59	164	3	EFO_0022337
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	COBLL1 PSD3 RRN3	4.36e-03	59	164	3	EFO_0022260
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	COBLL1 PSD3 RRN3	4.57e-03	60	164	3	EFO_0021898
Disease	response to cranial radiation therapy, short-term memory	MPP2 MALRD1 ACKR3	4.57e-03	60	164	3	EFO_0004335, EFO_0010950
Disease	mean platelet volume	SEMA4F ACOX1 SIDT1 PSD3 F2RL1 SVEP1 FAH NFE2L1 ANKRD28 GNAS LY75 MAP2K1 PCDHGA8	4.71e-03	1020	164	13	EFO_0004584
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	TDRD15 COBLL1 GAB2 RRN3	4.72e-03	121	164	4	EFO_0008595, EFO_0020943
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B CCKBR ACE2	4.79e-03	61	164	3	DOID:3587 (is_marker_for)
Disease	anorectal malformation	TRPM2 MUC5B	4.93e-03	19	164	2	MONDO_0019938
Disease	triglycerides in medium LDL measurement	TDRD15 COBLL1 PSD3	5.01e-03	62	164	3	EFO_0022322
Disease	total lipids in chylomicrons and extremely large VLDL measurement	COBLL1 PSD3 RRN3	5.01e-03	62	164	3	EFO_0022306
Disease	free cholesterol in chylomicrons and extremely large VLDL measurement	COBLL1 PSD3 RRN3	5.01e-03	62	164	3	EFO_0022263
Disease	triglycerides to total lipids in medium VLDL percentage	TDRD15 COBLL1 RRN3	5.24e-03	63	164	3	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	TDRD15 COBLL1 RRN3	5.24e-03	63	164	3	EFO_0022239
Disease	free cholesterol to total lipids in medium LDL percentage	COBLL1 PSD3 RRN3	5.24e-03	63	164	3	EFO_0022283
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	COBLL1 PSD3 RRN3	5.24e-03	63	164	3	EFO_0022292
Disease	alpha-tocopherol measurement	PRKCE USH2A	5.46e-03	20	164	2	EFO_0007898
Disease	cholesteryl esters to total lipids in medium VLDL percentage	TDRD15 COBLL1 RRN3	5.48e-03	64	164	3	EFO_0022253

Protein segments in the cluster

Peptide	Gene	Start	Entry
VYQDNVYSPDCRFHS	GPT2	301	Q8TD30
YPDCLAQAIYATFHE	FAM227B	251	Q96M60
LCHYATSYQDENFPR	CYP27C1	441	Q4G0S4
YLAYCANHPSAVNVL	ARHGEF6	331	Q15052
GFHIVYQAYQLQSCP	CSMD3	2211	Q7Z407
YYDQCETHFISLLNA	NEDD9	711	Q14511
NYHILSPCDLSNYTD	CPSF3	491	Q9UKF6
VCSTPQSQYYLAEKH	BTK	336	Q06187
CFQNIYIFHKPSSYC	ADGB	641	Q8N7X0
NHALYAICDVFTQYL	ARFGEF1	1456	Q9Y6D6
TYLHSVLNPVVYCFS	GPR31	271	O00270
PLHYAAANCNYQCLF	ANKRD28	441	O15084
DTISEYIYHCNAQNP	ABHD4	236	Q8TB40
LSVYHPQLAYCVVQF	PPP2R5D	336	Q14738
SVYHPQLAYCVVQFL	PPP2R5C	261	Q13362
YLTYCANHPSAVNVL	ARHGEF7	361	Q14155
FSHYEYLCALQNSVP	CEP78	16	Q5JTW2
HLLSYASACVNPLVY	CCKBR	376	P32239
LQFSNDIYSTYHLFP	DCPS	106	Q96C86
DFTVNYCISYHLCPH	DISP2	1031	A7MBM2
FLCAQYHLNPSSYTI	COBLL1	86	Q53SF7
FQYPASYHSNQTLAL	CTNND2	166	Q9UQB3
QVLHECNSPYIVGFY	MAP2K1	116	Q02750
NLSLYLDNHYCTASA	MUC5B	5111	Q9HC84
YQDPAQLSCLPYLEH	NFE2L1	556	Q14494
HALAFCESLYDPYRN	NBEAL1	151	Q6ZS30
LTFCLEYEQHPDEYQ	CHML	301	P26374
LCFSNGNHYDIVYPI	OTUD4	141	Q01804
LNHINHFYCDTLPLY	OR5K2	171	Q8NHB8
LHYYNVPLCVTEETF	HNRNPLL	456	Q8WVV9
FYTCHLPQDLAVAQY	NUP107	591	P57740
TFPHASYSAYILENN	PCDHGA8	451	Q9Y5G5
AYDHFVAICNPLLYT	OR5D16	121	Q8NGK9
LNYFDYHQQTLPLGC	PCDH19	811	Q8TAB3
VYLDLCYIPNHSNSK	MAP1B	2356	P46821
ESICSTYSNLYNHPQ	LTV1	351	Q96GA3
FHPYTRYENITFNCC	BLZF1	376	Q9H2G9
NFPYSLEHLQTSYCG	LRR1	151	Q96L50
HPYLTQLYCCFQTKD	PRKCE	466	Q02156
IGYLKQNTYCFPHSL	GAPVD1	266	Q14C86
PQELLGTSCYEYFHQ	ARNTL2	396	Q8WYA1
YLYLLFDPTNFIHNN	EDEM2	436	Q9BV94
LLLSMNPYDYHFCSQ	MYH7B	346	A7E2Y1
YHDNCLPTIFVYKNG	PDCL2	156	Q8N4E4
PCLNEYTAISYYHSQ	FAT2	4266	Q9NYQ8
NALSHSYCYHPDVIQ	OR51F1	181	A6NGY5
QPEDFATYYCLQHNS	IGKV1D-17	101	A0A075B6S4
LNYEEAVLYCASNHS	LY75	831	O60449
FERSGLAYCPNDYHQ	LPXN	191	O60711
NDYHQLFSPRCAYCA	LPXN	201	O60711
YVQCHAPTSSAYEFV	MED25	81	Q71SY5
IYNPDYYSNLHQTFL	METTL18	296	O95568
YQEALHNCSNEHYPV	TUBGCP6	506	Q96RT7
YGHYFDLCLVNSNLE	MPP2	536	Q14168
LEHTYLPQVSHYRFC	EXOC6B	166	Q9Y2D4
PHSFYSFELIVVQNY	KBTBD7	471	Q8WVZ9
HQSILELFNTSYCPY	ENTPD1	326	P49961
LCHLASGAADAYYQF	IMPA2	211	O14732
HTYSCLYGTFLANNP	MTMR4	501	Q9NYA4
SNHINHFYCDILPLY	OR5K1	171	Q8NHB7
IPNTNYCVSVYLEHS	IFNAR2	201	P48551
LSAAHCFQKHYYPSE	PRSS41	91	Q7RTY9
AQNAYSRHCPFYVSI	GPR160	166	Q9UJ42
PYASCHIFELYQEDS	ACP2	306	P11117
LSPHSQEVSCYIDYN	POMT1	421	Q9Y6A1
DQRNASYPHCLQFYL	PRIM2	16	P49643
YQFTSFLSPGIIYHC	PREP	396	P48147
NSCIDPFVYYFVSHD	F2RL1	336	P55085
CFHYPKYFQSQVHVE	PLA2G4E	261	Q3MJ16
LPTNDQHDCQITFYY	MALRD1	136	Q5VYJ5
CYPSAKNHEQTFSYF	CFAP300	231	Q9BRQ4
YSHCSGLPNIYVNFT	ACOX1	401	Q15067
INPQYHFSEDYLECV	GPC6	176	Q9Y625
ALVHDYFSALPSQLY	CDK15	381	Q96Q40
HFPFLYNNHNYTDCT	FN1	421	P02751
DCITYISSHPNFKDY	COG3	231	Q96JB2
CILLLHISYVANYPN	FRRS1	11	Q6ZNA5
DCQEFYRALYIHAQP	CARD19	76	Q96LW7
LQSSACYSPHAAYAQ	DHRSX	196	Q8N5I4
NNETYCRSFYPEHSI	ACKR3	191	P25106
TYCDPASLFHVSNDY	ACE2	496	Q9BYF1
HYVNCEDSYVASLQP	CEP85L	406	Q5SZL2
FSIYPVTQVAHNYCT	COL27A1	216	Q8IZC6
YVCHNPTNFYFSLHI	LYST	2026	Q99698
NICHLNYFTFSPIYD	MANBA	211	O00462
YQLHPSQAYCTDDNE	LTBP2	876	Q14767
QPEDFATYYCLQHNS	IGKV1-17	101	P01599
YVQIFYDTTNHFLPL	HYAL1	286	Q12794
YNQDSLIACVLPYHE	HEATR1	126	Q9H583
YLCHDEPYTFDINLS	FAH	286	P16930
NFRHEYLPTIENTYC	DIRAS3	61	O95661
INQYFTNHCLYFLST	RYR1	3006	P21817
YNLTHLQPSTDYEVC	LRRN1	581	Q6UXK5
QFPFLSCHEYIDPYL	OTOGL	326	Q3ZCN5
ICLNSQLHTPMYYFL	OR8A1	66	Q8NGG7
NDTHCIDFSYLLYSQ	PTPRK	101	Q15262
EPFGYNVTRCHSYNL	PTPRM	401	P28827
LHTQLQYECISPFYR	PAMR1	406	Q6UXH9
CYTPHNFTRDQALYA	PANX2	81	Q96RD6
ICQDFTEYKYTHQPN	NR6A1	421	Q15406
TSAPQEYLYLHQCIS	GAB2	186	Q9UQC2
VQPHAYQFTYRVTEC	PLAC1	66	Q9HBJ0
ALHGPFYSACQAVFY	RRN3	451	Q9NYV6
ALNPEYYCGSQHRLF	SZT2	356	Q5T011
VTPTASSYAHCNYFQ	HSF5	326	Q4G112
HPYTAYKFQVEACTS	USH2A	2591	O75445
HCYEPYIQNGNFTTS	SEZ6L	566	Q9BYH1
CYHVCPNYTNFQFDT	SIDT2	566	Q8NBJ9
EYPVILSFENHCSKY	PLCB4	401	Q15147
LFCGITQAHYTYNNL	SLC9A6	356	Q92581
DSCLTRFAVPHTYNY	SEMA4F	51	O95754
NLHTLKFYCLPDNYE	USP39	166	Q53GS9
TPTSVNYHFTRQCNY	RSAD2	71	Q8WXG1
YLPVTYHINNADVSF	TMEM132D	46	Q14C87
LNCSVENTHPTVSYY	TMEM255A	256	Q5JRV8
ISHIYSPQKFYCQLG	TDRD15	971	B5MCY1
CQPYRSAFYVLEQQH	NBPF10	2361	Q6P3W6
YQYHVTFSPNVECKS	PIWIL2	241	Q8TC59
HAGPISFFYDIINYC	SLC26A8	256	Q96RN1
AQHVYPFSSLQCFAS	PML	766	P29590
YCYPHFTCAVDTENI	GNAS	1001	Q5JWF2
NKYIAHSCNFYLFPT	PNLDC1	71	Q8NA58
DNDPSAQFHYLIQVY	PKD1L3	736	Q7Z443
QYLLCPHSAVAVNYH	THNSL2	386	Q86YJ6
HYCQADNTYTCLVPE	TANC1	506	Q9C0D5
HYCQADNAYTCLVPE	TANC2	456	Q9HCD6
QSASYYPVCHSKLDL	TANC2	1721	Q9HCD6
CPHNYLVYVEAFSQH	SAMD10	131	Q9BYL1
AVYHSIDAYFQPCQD	CCT8L1P	391	A6NM43
DSCKFLLDNPYTHTY	PLA2G1B	81	P04054
YFCQLIDGLEYLHSQ	STK11	156	Q15831
YCENPEAHLATEYVQ	PLB1	1216	Q6P1J6
FLQPYNASHLYVCGT	SEMA4C	116	Q9C0C4
NCPLGTYYNLEHFTC	SVEP1	1001	Q4LDE5
FYACCLQYQEALSHP	NUP160	531	Q12769
YNVISHFYCDSLPLL	OR8K3	171	Q8NH51
TYANSCANPILYAFL	SSTR2	301	P30874
VPHSQAEEFYVCIYA	ACLY	111	P53396
AIAHPYSQALIQYVC	SUPT6H	976	Q7KZ85
YLYDLNHTLYNVQSC	UNC93B1	246	Q9H1C4
VYLSPNVECDLTYHN	UBE3A	261	Q05086
LCSYFFEAEPRQHLY	RBP3	796	P10745
ASYTESCIQEHYLPQ	TCEANC	271	Q8N8B7
YASNLIFVLYHCENA	MINPP1	411	Q9UNW1
QAQAPCHYEGKYFTL	MSMP	41	Q1L6U9
FRLHSPCALYGYNFS	TBX18	521	O95935
CRPHYFIFNSQTVYA	SLC38A2	281	Q96QD8
ALYPQTTCFYRALIH	SGF29	236	Q96ES7
YLYENLDPSCLFHSK	TRPM2	521	O94759
CYHVCPNYSNFQFDT	SIDT1	561	Q9NXL6
VHLQLPRSDLYNCFY	TBC1D23	136	Q9NUY8
YITFFCPHDLVSQGY	TMEM38B	91	Q9NVV0
LNRHSYPNVYFCLHF	ZNF654	806	Q8IZM8
YPNVYFCLHFNCNES	ZNF654	811	Q8IZM8
ALHGPFYSACQAVFY	RRN3P1	76	Q2M238
DLHYCFNVYITGHPQ	TEX10	906	Q9NXF1
YQFTARYHAAPCNSI	ZPBP	171	Q9BS86
RYHAAPCNSIYNISF	ZPBP	176	Q9BS86
PNQDDFHSSEYAYRC	nan	461	Q3C1V9
YGENFNHCSPLNTYE	ZNF112	336	Q9UJU3
SSLTQPSDNLLHYCY	VPS13B	716	Q7Z7G8
AFTIQVPQYIDYCHN	VPS13B	926	Q7Z7G8
IPYTFHQDNNFLYLC	XPNPEP3	111	Q9NQH7
ICANYDIPHIVNNAY	SEPSECS	241	Q9HD40
CALSINHSNSYLAYP	WIPI1	146	Q5MNZ9
CAYDLDNYQTTFHPV	ZP2	566	Q05996
QECLFYLHNYSTNLA	ZFYVE26	2161	Q68DK2
LIHFSNRYFYCNPDT	PSD3	656	Q9NYI0
DYNYPLCALQAFAIA	TUB	481	P50607
PKCVFTYVQSLYNHL	SMTN	891	P53814
LVFLYQNFYAHLPES	TOE1	196	Q96GM8
LYEYKECHQIFNQSP	ZNF606	316	Q8WXB4
HNDCSEFVNQPYLLY	GUCY1A1	241	Q02108
CSHYLIQELNSFNYL	KLHL32	131	Q96NJ5